Aug 9, 2019, 01:00 by admin admin

In the wake of the introduction of the Overdose Prevention and Patient Safety (OPPS) Act, a bill that would amend the federal statute underlying the addiction treatment privacy regulations known as 42 CFR Part 2 (“Part 2”), ASAM has received many questions about our support for the bill and our position on changing Part 2.

Aug 9, 2019, 01:00 by admin admin

The opioid epidemic continued throughout the United States in 2017. State legislatures have remained engaged on this issue, with every state enacting some type of measure supporting prevention, treatment, or recovery in the past two years.

Aug 9, 2019, 01:00 by admin admin

Today, the Department of Health and Human Services (HHS) issued their Mental Health and Substance Use Disorder Parity Action Plan. Congress included a provision in Section 13002 of the 21st Century Cutes Act requiring HHS to create this Action Plan detailing recent and planned actions from the Departments of HHS, Labor, and Treasury related to ongoing implementation of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act (MHPAEA).

Aug 9, 2019, 01:00 by admin admin

Penny Mills, ASAM’s Executive Vice President (EVP) and CEO, has decided she will retire at the beginning of June 2020.

Aug 9, 2019, 01:00 by admin admin

The briefing, titled “Transforming Addiction Treatment: A Bigger, Bolder Response to America’s Opioid Overdose Epidemic,” brought together experts working on the front lines of addiction treatment to discuss the comprehensive approach needed to stem the tide of a public health emergency that claimed 42,249 lives in 2016.

Aug 9, 2019, 01:00 by admin admin

Washington, DC – ACOG, AAP, ASAM, March of Dimes and NOFAS released a statement in response to the policy instituted by the Big Horn County Attorney’s Office in Montana to prosecute and incarcerate pregnant women for drug/alcohol use.

Aug 9, 2019, 01:00 by admin admin

The Coalition to Stop Opioid Overdose (CSOO) is excited to welcome the Academy of Integrative Pain Management (AIPM) as the newest member of the coalition. Founded in 1988, AIPM is a diverse community of healthcare providers representing more than 30 distinct disciplines who are dedicated to using all appropriate therapeutic approaches to reduce pain and achieve optimal health and healing.

Aug 9, 2019, 01:00 by admin admin

ASAM commends CMS for issuing this new guidance which expands access to care and requires states to align their section 1115(a) demonstrations with certain goals and milestones.

Aug 9, 2019, 01:00 by admin admin

Dr. Ilse Levin and Kelly Corredor attended the AMA's 2020 National Advocacy Conference.

Aug 9, 2019, 01:00 by admin admin

The Partnership to Amend 42 CFR Part 2 sent a letter urging Senator Lamar Alexander to help align 42 CFR Part 2 with HIPAA.

Aug 9, 2019, 01:00 by admin admin

The dearth of FDA-approved pharmacotherapies for the treatment of substance use disorder (SUD) prompted ASAM to write to the Food and Drug Administration urging them to take into consideration the need for access to multiple treatment options for clinicians and their patients as they consider applications for new products to treat SUD.

Aug 9, 2019, 01:00 by admin admin

The Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) state and local health departments, and other clinical and public health partners are investigating a national outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI). As of December 10, 2019, a total of 2,409 hospitalized EVALI cases have been reported to CDC from all 50 states, the District of Columbia, and two U.S. territories (Puerto Rico and U.S. Virgin Islands). Fifty-two deaths have been confirmed in 26 states and the District of Columbia.

Aug 9, 2019, 01:00 by admin admin

On April 11, 2017, ASAM and 19 members of the Coalition to Stop Opioid Overdose sent a letter to the Chairmen and Ranking Members of the House and Senate Committees on Appropriations requesting full funding for the Comprehensive Addiction and Recovery Act (CARA) in the Fiscal Year 2017 and 2018 appropriations bills.

Aug 9, 2019, 01:00 by admin admin

The American Society of Addiction Medicine is pleased to hear that The ASAM Criteria was included in today’s discussion about solutions to combat the opioid misuse and overdose crisis. Addressing this public health emergency will require systemic and sustainable changes to our addiction treatment infrastructure and workforce, as well as expanded access to comprehensive, evidenced-based treatment that includes all levels of care. 

Aug 9, 2019, 01:00 by admin admin

Today the American Society of Addiction Medicine (ASAM) submitted a letter to the House Committee on Energy and Commerce as it considers legislation to address the opioid misuse, addiction, and overdose epidemic. The letter, submitted to Chairman Greg Walden (R-OR) and Ranking Member Frank Pallone (D-NJ), urges the Committee to approve bills that expand the provision of evidence-based treatment, strengthen America’s addiction treatment infrastructure, and bolster the nation’s addiction treatment workforce.

Aug 9, 2019, 01:00 by admin admin

Updated definition of addiction to explain more fully the complexity of this chronic disease with the intent of driving a bold and comprehensive national response.

Aug 9, 2019, 01:00 by admin admin

ASAM sent letters of support for the Removing Barriers to Medicaid and CHIP Addiction Treatment Act and the Medicaid Coverage for Addiction Recovery Treatment Act. These bills would work to repeal Medicaid Institutions for the Mental Diseases (IMD) exclusion for mental health and substance use disorder residential treatment facilities. 

Aug 9, 2019, 01:00 by admin admin

On May 16, the Food and Drug Administration (FDA) announced its approval Lucemyra, the first non-opioid treatment for management of opioid withdrawal symptoms. Lucemyra (lofexidine hydrochloride) reduces the release of norepinephrine and can be used to lessen the severity of withdrawal symptoms that may occur after the discontinuation of opioid use.

Aug 9, 2019, 01:00 by admin admin

ASAM took the opportunity to advocate for standardization of addiction treatment when MACPAC released its request for information on the Medicaid IMD Additional INFO Act.

Aug 9, 2019, 01:00 by admin admin

The Coalition to Stop Opioid Overdose (CSOO) welcomes HIV Alliance as a new member of the coalition. HIV Alliance was formed in 1994 to support individuals living with HIV/AIDS and prevent new HIV infections.